Health Canada approves expanded indication for Soliqua


18 December 2020 - New indication for Soliqua offers an alternative approach for Canadians living with type 2 diabetes requiring treatment intensification.

Sanofi Canada announced that Health Canada has approved expanded use of Soliqua The once daily injection, is now indicated in combination with metformin as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin (less than 60 units daily) alone or in combination with metformin or a glucagon-like peptide-1 receptor agonist in combination with metformin.

Read Sanofi press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , Canada